Psychological Experiences in Women with Polycystic Ovary Syndrome: A Qualitative Study

Ziba Farajzadegan, Ashraf Kazemi, Mehrdad Salehi, Fatemeh ZareMobini

Abstract


Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women of reproductive years. In addition to multiple physical problems, this syndrome has many psychological complications. Thus, the present study attempted to explore the psychological experiences of women with PCOS in Iran’s sociocultural context.

Materials and Methods: The study was carried out in Isfahan, Iran, using a qualitative content analysis method. The participants were selected through purposive sampling from women with PCOS, their spouses, and healthcare providers in hospitals, clinics, workplaces, universities, and physicians’ offices between September 2018 and November 2019. Data collection was performed through semi‑structured interviews until data saturation. Data analysis was based on conventional content analysis. The interviews were transcribed and coded. Afterward, categories and concepts were extracted by grouping similar codes.

Results: A total of 13 women with PCOS, four spouses, and 13 healthcare providers participated in this study. Data analysis yielded five main categories, including the patient’s psychological reactions following infertility and its probability, psychological issues following menstrual disorders, patients’ fear and concerns about the probability of developing chronic diseases, psychological problems following the disease, and psychological problems resulting from body appearance.

Conclusions: The results of this study showed that women with PCOS were exposed to multiple psychological problems. Therefore, preventing and controlling the psychological consequences of PCOS and its complications requires healthcare providers’ support and comprehensive and long‑term planning to promote the mental health of these women.



Keywords


Mental health, Polycystic ovary syndrome, Psychological, Qualitative research

Full Text:

PDF

References


Naz MSG, Tehrani FR, Majd HA, Ahmadi F, Ozgoli G, Fakari FR, Ghasemi V. The prevalence of polycystic ovary syndrome in adolescents: A systematic review and meta analysis. Int J Reprod BioMed 2019;17:533-42.

Spritzer PM, Marchesan LB, Santos BR, Cureau FV, Oppermann K, dos Reis RM, et al. Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: Protocol for a nation wide case–control study. BMJ Open 2019;9:e029191.

Lentscher JA. Decherney AH. Clinical presentation and diagnosis of polycystic ovarian syndrome. Clin Obstet Gynecol 2021;64:3-11.

Fattah A, Hadavi F, Bahrami F, Khoshlholgh R, Ahmadi A, Mahmoodabadi M, et al. Prevalence of Polycystic Ovary Syndrome (PCOS) among students of Kerman University of Medical Sciences and a meta analysis of the prevalence of PCOS among Iranian adolescent. Int J Pediatr 2021;9:13957 69.

Rodriguez Paris V, Bertoldo MJ. The mechanism of androgen actions in PCOS etiology. Med Sci (Basel) 2019;7:89.

Avery JC, Moran LJ, Moore V, Fernandez RC, Whitrow M, Stocks N, et al. Prevalence of self reported polycystic ovary syndrome and profiles of health among women of different generations: A cross sectional study. Fertility & Reproduction 2019;1:141 7.

Layacha SY, Biswas DA. Women with polycystic ovary syndrome: A review of susceptibility to type 2 diabetes. Cureus 2023;15:e33390.

Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke. Diabetes 2021;70:627-37.

Rudnicka E, Suchta K, Grymowicz M, Calik Ksepka A, SmolarczykK, Duszewska AM, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci 2021;22:3789.

Duica F, Danila CA, Boboc AE, Antoniadis P, Condrat CE, Onciul S, et al. Impact of increased oxidative stress on cardiovascular diseases in women with polycystic ovary syndrome. Front Endocrinol (Lausanne) 2021;12:614679.

Stańczyk A, Kolmaga A, Burzyńska M. Lifestyle and psychosocial risks among women with polycystic ovary syndrome and insulin resistance. Med Og Nauk Zdr 2021;27:312-7.

Hasan M, Sultana S, Sohan M, Parvin S, Rahman MA, Hossain MJ, et al. Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross sectional study. PLoS One 2022;17:e0270102.

Asik M, Altinbas K, Eroglu M, Karaahmet E, Erbag G, Ertekin H, et al. Evaluation of affective temperament and anxiety depression levels of patients with polycystic ovary syndrome. J Affect Disord 2015;185:214 8.

Galderisi S, Heinz A, Kastrup M, Beezhold J, Sartorius N. Toward a new definition of mental health. World Psychiatry 2015;14:231-3.

Banting LK, Gibson Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health 2014;14:51.

Li M, Ruan X, Mueck A O. Management strategy of infertility in polycystic ovary syndrome. Glob Health J 2022;6:70 4.

Arentz S, Smith CA, Abbott J, Bensoussan A. Perceptions and experiences of lifestyle interventions in women with polycystic ovary syndrome (PCOS), as a management strategy for symptoms of PCOS. BMC Women’s Health 2021;21:107.

Behboodi Moghadam Z, Fereidooni B, Saffari M, Montazeri A. Polycystic ovary syndrome and its impact on Iranian women’s quality of life: A population based study. BMC Women’s Health 2018;18:164.

Hart R, Doherty DA, The potential implications of a PCOS diagnosis on a woman’s long term health using data linkage. J Clin Endocrinol Metab 2015;100:911 9.

Ogden J, Bridge L. How communicating a diagnosis of polycystic ovarian syndrome (PCOS) impacts wellbeing: A retrospective community survey. BJGP Open 2022;6:BJGPO.2022.0014. doi: 10.3399/BJGPO.2022.0014.

Creswell JW, Creswell JD. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches. California: Sage Publications; 2017.

Hadjiconstantinou M, Mani H, Patel N, Levy M, Davies M, Khunti K, et al. Understanding and supporting women with polycystic ovary syndrome: A qualitative study in an ethnically diverse UK sample. Endocr Connect 2017;6:323 30.

Shayan A, Masoumi SZ, Shobeiri F, Tohidi S, Khalili A. Comparing the effects of agnugol and metformin on oligomenorrhea in patients with polycystic ovary syndrome: A randomized clinical trial. J Clin Diagn Res 2016;10:QC13 6.

Zaremobini F, Kazemi A, Farajzadegan Z. A comprehensive mental health care program for women with polycystic ovary syndrome: Protocol for a mixed methods study. Reprod Health 2018;15:46.

Jiskoot G, Benneheij SH, Beerthuizen A, de Niet JE, de Klerk C, Timman R, et al. A three component cognitive behavioural lifestyle program for preconceptional weight loss in women with polycystic ovary syndrome (PCOS): A protocol for a randomized controlled trial. Reprod Health 2017;14:34.

Williams S, Sheffield D, Knibb RC. Everything’s from the inside out with PCOS’: Exploring women’s experiences of living with polycystic ovary syndrome and co morbidities through Skype™ interviews. Health Psychol Open 2015;2:255102915603051.

Moradi F, Ghadiri Anari A, Dehghani A, Vaziri SR, Enjezab B. The effectiveness of counseling based on acceptance and commitment therapy on body image and self esteem in polycystic ovary syndrome: An RCT. Int J Reprod Biomed 2020;18:243-52.


Refbacks

  • There are currently no refbacks.